Since Cleveland Clinic’s founding in 1921, research and innovation have been integral parts of the enterprise mission. Not only did the founders believe it was important to treat disease, but also to investigate the causes of disease. Nearly 100 years later, Cleveland Clinic Lerner Research Institute is at the forefront of biological discovery, conducting basic, translational and clinical research related to cancer, cardiovascular and metabolic diseases, brain and eye diseases, and diseases of the inflammation and immune systems. Our mission is to uncover the biological pathways of disease; develop new medical devices, diagnostic and treatment therapies, and cures; and train the next generation of biomedical researchers.
Lerner Research Institute is home to all basic, translational and clinical research at Cleveland Clinic. With nearly 1,400 researchers and support personnel in 180 laboratories in 11 departments, we are one of the largest research institutes in the nation, consistently ranking in the top 10 in National Institutes of Health funding, a benchmark of research success.
Innovations And Commercialization